Michael Wenger
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 45
- Genetics 43
- Chronic Lymphocytic Leukemia Research 43
- Co-authors
- Gilles Salles (16 shared papers)Nancy Valente (4 shared papers)Peter Berchtold (2 shared papers)Guillaume Cartron (14 shared papers)Franck Morschhauser (16 shared papers)Helmut Segner (8 shared papers)Martin Barrett (1 shared paper)Susan O’Brien (1 shared paper)
- Journals
- Blood (38 papers)Journal of Clinical Oncology (9 papers)Behavioural Brain Research (1 paper)Brain Research (1 paper)Cell and Tissue Research (1 paper)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Michael Wenger
69 papers receiving 3.5k citations
Michael Wenger's Hit Papers
Peers
Comparison fields: 5 of 110
- Genetics 1.7k
- Pathology and Forensic Medicine 2.1k
- Immunology 1.1k
- Oncology 1.1k
- Hematology 447
Countries citing papers authored by Michael Wenger
This map shows the geographic impact of Michael Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wenger more than expected).
Fields of papers citing papers by Michael Wenger
This network shows the impact of papers produced by Michael Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wenger. The network helps show where Michael Wenger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Wenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obinutuzumab for the First-Line Treatment of Follicular Lymphoma Hit paper breakdown → | 2017 | 461 |
| 2 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience Hit paper breakdown → | 2017 | 396 |
| 3 | 2010 | 358 | |
| 4 | 2012 | 305 | |
| 5 | 2012 | 186 | |
| 6 | 2013 | 157 | |
| 7 | 2013 | 129 | |
| 8 | 2014 | 125 | |
| 9 | 1993 | 119 | |
| 10 | 2003 | 117 | |
| 11 | The effects of rituximab treatment during pregnancy on a neonate. | 2006 | 106 |
| 12 | 2013 | 101 | |
| 13 | 2011 | 82 | |
| 14 | 2007 | 78 | |
| 15 | 2012 | 71 | |
| 16 | 2012 | 64 | |
| 17 | 2011 | 64 | |
| 18 | 2008 | 50 | |
| 19 | 2016 | 40 | |
| 20 | 1997 | 35 |
About Michael Wenger
Michael Wenger is a scholar working on Pathology and Forensic Medicine, Genetics, Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 70 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (43 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Acute Lymphoblastic Leukemia research (8 papers), CAR-T cell therapy research (8 papers), Aquaculture disease management and microbiota (6 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Genetics (1.7k citations), Pathology and Forensic Medicine (2.1k citations), Immunology (1.1k citations), Oncology (1.1k citations) and Hematology (447 citations). Michael Wenger has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Gilles Salles, Nancy Valente, Peter Berchtold, Guillaume Cartron, Franck Morschhauser, Helmut Segner, Martin Barrett, Susan O’Brien, Robin Foà and J Maurer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Behavioural Brain Research, Brain Research and Cell and Tissue Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.